Talphera, Inc. (TLPH)
NASDAQ: TLPH · Real-Time Price · USD
0.5300
+0.0350 (7.07%)
Apr 1, 2025, 4:00 PM EDT - Market closed
Talphera Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
15
Market Cap
9.03M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
TLPH News
- 22 hours ago - Talphera, Inc. (TLPH) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 1 day ago - Talphera Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 1 day ago - Talphera Announces Agreement with the FDA to Reduce the NEPHRO CRRT Study Size to 70 Patients From 166 and a Private Placement Financing Priced At-the Market of up to $14.8 Million - PRNewsWire
- 6 days ago - Talphera to Host Fourth Quarter and Full-Year 2024 Financial Results and Corporate Update Call and Webcast on Monday, March 31, 2025 - PRNewsWire
- 2 months ago - Talphera Announces Agreement with the FDA for Prior Approval Supplement Review to Reduce the Number of Patients in the NEPHRO CRRT Study - PRNewsWire
- 4 months ago - Talphera, Inc. (TLPH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Talphera Announces Third Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 5 months ago - Talphera to Host Third Quarter 2024 Financial Results and Corporate Update Call and Webcast on Wednesday, November 13, 2024 - PRNewsWire